Medprin Financial Statements From 2010 to 2025

Stocks . China . 
Stock . Medprin Regenerative Medical
301033 Stock   47.80  0.31  0.64%   
Medprin Regenerative financial statements provide useful quarterly and yearly information to potential Medprin Regenerative Medical investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Medprin Regenerative financial statements helps investors assess Medprin Regenerative's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Medprin Regenerative's valuation are summarized below:
Gross Profit
220.5 M
Profit Margin
0.2473
Market Capitalization
3.2 B
Enterprise Value Revenue
10.9466
Revenue
276 M
We have found fifty-two available fundamental ratios for Medprin Regenerative, which can be analyzed and compared to other ratios and to its peers in the industry. All investors should make sure to check all of Medprin Regenerative last-minute market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road.

Medprin Regenerative Total Revenue

179.67 Million

Check Medprin Regenerative financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medprin Regenerative's main balance sheet or income statement drivers, such as Tax Provision of 6.1 M, Interest Income of 2.3 M or Selling General Administrative of 39.6 M, as well as many indicators such as . Medprin financial statements analysis is a perfect complement when working with Medprin Regenerative Valuation or Volatility modules.
  
This module can also supplement various Medprin Regenerative Technical models . Check out the analysis of Medprin Regenerative Correlation against competitors.

Medprin Regenerative Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets676.3 M905 M482.2 M
Slightly volatile
Other Current Liabilities657.1 K728.5 K1.2 M
Slightly volatile
Total Current Liabilities65 M78.3 M46.1 M
Slightly volatile
Total Stockholder Equity537.7 M731.2 M400.3 M
Slightly volatile
Accounts Payable33.9 M36.7 M25.2 M
Slightly volatile
Cash26.9 M30.7 M27.2 M
Very volatile
Non Current Assets Total368.2 M594.8 M230.7 M
Slightly volatile
Non Currrent Assets Other66.7 M63.5 M16.4 M
Slightly volatile
Net Receivables21.8 M20.8 M7.9 M
Slightly volatile
Common Stock Shares Outstanding65.4 M76 M55.3 M
Slightly volatile
Short Term Investments234.9 M221.7 M181.2 M
Slightly volatile
Non Current Liabilities Total71.2 M95.4 M33 M
Slightly volatile
Inventory24 M30.1 M19.2 M
Slightly volatile
Other Current Assets60 K63.1 K12.5 M
Slightly volatile
Total Liabilities136.2 M173.8 M79 M
Slightly volatile
Net Invested Capital591.8 M784.6 M422.4 M
Slightly volatile
Total Current Assets308.1 M310.2 M251.5 M
Slightly volatile
Capital Stock65.4 M76 M55.3 M
Slightly volatile
Net Working Capital176.8 M181.4 M198.2 M
Pretty Stable
Intangible Assets80.8 M108.4 M63.5 M
Slightly volatile
Property Plant And Equipment Net273.8 M367 M180.7 M
Slightly volatile
Net Debt30.4 M17.8 M34.9 M
Pretty Stable
Long Term Debt49.2 M41.8 M50.7 M
Pretty Stable
Capital Lease Obligations867.3 K912.9 K5.6 M
Slightly volatile
Property Plant And Equipment Gross305 M419.7 M203.7 M
Slightly volatile

Medprin Regenerative Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Tax Provision6.1 M8.2 M4.6 M
Slightly volatile
Interest Income2.3 M2.2 M775.2 K
Slightly volatile
Selling General Administrative39.6 M61.8 M21.4 M
Slightly volatile
Total Revenue179.7 M265.5 M142.6 M
Slightly volatile
Gross Profit149.6 M217.7 M120 M
Slightly volatile
Operating Income38.7 M52 M30.8 M
Slightly volatile
Net Income From Continuing Ops40.9 M47 M32.6 M
Slightly volatile
Research Development25.9 M30.8 M21.1 M
Slightly volatile
EBITDA50.2 M69.3 M43.9 M
Slightly volatile
Cost Of Revenue30.1 M47.8 M22.6 M
Slightly volatile
Total Operating Expenses141 M213.5 M111.8 M
Slightly volatile
Reconciled Depreciation30.6 M29.1 M9.9 M
Slightly volatile
Income Before Tax47 M55.2 M37.2 M
Slightly volatile
Net Income40.9 M47 M32.7 M
Slightly volatile
Minority Interest110.6 K180.4 K110.5 K
Slightly volatile
Interest Expense1.4 M2.3 M823.5 K
Slightly volatile

Medprin Regenerative Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow29.4 M40.3 M66.2 M
Slightly volatile
Depreciation30.6 M29.1 M9.9 M
Slightly volatile
Capital Expenditures43.8 M46.1 M53 M
Slightly volatile
Total Cash From Operating Activities63.3 M123.8 M47.3 M
Slightly volatile
Net Income41 M47 M32.7 M
Slightly volatile
End Period Cash Flow26.7 M30.7 M27 M
Very volatile
Dividends Paid12.8 M17.6 M9.4 M
Slightly volatile

About Medprin Regenerative Financial Statements

Medprin Regenerative stakeholders use historical fundamental indicators, such as Medprin Regenerative's revenue or net income, to determine how well the company is positioned to perform in the future. Although Medprin Regenerative investors may analyze each financial statement separately, they are all interrelated. For example, changes in Medprin Regenerative's assets and liabilities are reflected in the revenues and expenses on Medprin Regenerative's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Medprin Regenerative Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue265.5 M179.7 M
Cost Of Revenue47.8 M30.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
CRMSalesforce
CRMSalesforce

Other Information on Investing in Medprin Stock

Medprin Regenerative financial ratios help investors to determine whether Medprin Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medprin with respect to the benefits of owning Medprin Regenerative security.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Cash Flow
Statement
Details
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY